(Q28294251)

https://api.crossref.org/works/10.1080/07357900801965034

Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2

20 April 2017

1 reference

https://api.crossref.org/works/10.1080/07357900801965034

Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)

20 April 2017

1 reference

https://api.crossref.org/works/10.1080/07357900801965034

Hairy cell leukemia: an update.

20 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Hairy cell leukemia in first cousins and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Hairy-cell leukaemia: biology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Hairy cell leukemia: an elusive but treatable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Hairy cell leukemia: a clinical review based on 71 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

The natural history and clinico-pathological features of the variant form of hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Hairy cell leukemia: characteristics of the neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

CD52 expression in hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Purine analogue combinations for indolent lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Splenectomy for hairy cell leukemia. A clinical review of 63 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

The treatment of hairy-cell leukaemia with 2'-deoxycoformycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

The clinical pharmacokinetics of cladribine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Rituximab in relapsed or refractory hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Monoclonal antibody therapy for hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Eradication of minimal residual disease in hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034

Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801965034